Insmed (INSM) Gains from Investment Securities (2010 - 2026)

Insmed's Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 123.18% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $184.5 million (up 37.81% YoY), while the FY2025 annual figure was $20.7 million, up 3.15% from the prior year.
• Gains from Investment Securities was $2.4 million for Q1 2026 at Insmed, down from $18.5 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $104.7 million in Q3 2025 to a low of -$21.6 million in Q4 2022.
• Historically, Gains from Investment Securities has averaged $18.0 million across 5 years, with a median of $5.2 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities jumped 1222.46% in 2024, then tumbled 1737.36% in 2025.
• A 5-year view of Gains from Investment Securities shows it stood at -$21.6 million in 2022, then soared by 108.97% to $1.9 million in 2023, then surged by 1222.46% to $25.7 million in 2024, then dropped by 27.97% to $18.5 million in 2025, then sank by 87.25% to $2.4 million in 2026.
• The last three Gains from Investment Securities figures came in at $2.4 million (Q1 2026), $18.5 million (Q4 2025), and $104.7 million (Q3 2025), per Business Quant data.